Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The Diagnostic Imaging Devices market in United Kingdom is experiencing steady growth due to increasing customer preferences for advanced imaging technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Customers in the United Kingdom are increasingly inclined towards advanced diagnostic imaging devices that offer higher accuracy and improved patient outcomes. There is a growing demand for devices that provide detailed images and enable early detection of diseases. Additionally, customers are also looking for devices that are portable, user-friendly, and have enhanced connectivity features to facilitate seamless integration with healthcare systems.
Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in the United Kingdom is the adoption of digital imaging technologies. Digital imaging devices offer several advantages over traditional film-based systems, such as faster image acquisition, improved image quality, and the ability to store and share images electronically. This trend is driven by the increasing need for efficient and cost-effective healthcare solutions. Another trend in the market is the integration of artificial intelligence (AI) in diagnostic imaging devices. AI algorithms can analyze medical images and assist healthcare professionals in making accurate diagnoses. This trend is expected to enhance the efficiency and accuracy of diagnostic imaging, leading to improved patient care.
Local special circumstances: The United Kingdom has a well-established healthcare system with a strong emphasis on research and development. The country has a high number of research institutions and academic centers that focus on medical imaging technologies. This creates a favorable environment for the development and adoption of advanced diagnostic imaging devices. Additionally, the National Health Service (NHS) in the United Kingdom plays a crucial role in driving the adoption of innovative medical technologies, including diagnostic imaging devices.
Underlying macroeconomic factors: The United Kingdom has a stable economy with a high level of healthcare expenditure. The government's focus on improving healthcare infrastructure and patient care has led to increased investments in diagnostic imaging devices. Additionally, favorable reimbursement policies and government initiatives to promote early detection and prevention of diseases have further fueled the demand for diagnostic imaging devices in the country. In conclusion, the Diagnostic Imaging Devices market in the United Kingdom is witnessing growth due to increasing customer preferences for advanced imaging technologies, the adoption of digital imaging and AI, local special circumstances such as a strong healthcare system and government support, and underlying macroeconomic factors such as stable economy and high healthcare expenditure. These factors are expected to continue driving the growth of the market in the coming years.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights